Values First Advisors, Inc. Myovant Sciences Ltd. Transaction History

Values First Advisors, Inc.

  • $182 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Nov 15, 2022
SELL
$7.34 - $20.84 $531,540 - $1.51 Million
-72,417 Closed
0 $0
Q1 2020

Jan 09, 2023
BUY
$6.55 - $14.76 $214,957 - $484,393
32,818 New
32,818 $248 Million
Q4 2019

Nov 15, 2022
BUY
$4.2 - $19.21 $304,151 - $1.39 Million
72,417 New
72,417 $1.12 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email